EphA2 antibodies directed against a cancer diagnosis.

An in vitro method of detecting the presence of metastatic cancer cells in a selected cell population comprising: testing at least a portion of the selected cell population compared to overexpression of EphA2, wherein overexpression it is indicative of the presence of a metastatic cancer cell in the selected cell population.